课题基金 / 基金详情

EAP CLIENT FOLLOW-UP AND FAMILY INVOLVEMENT

EAP CLIENT FOLLOW-UP AND FAMILY INVOLVEMENT
EAP 客户跟进和家人参与
批准号:
3212528
负责人:
JOHN C ERFURT
金额:
$16.38万
依托单位国家:
美国
项目类别:
财政年份:
1990
资助国家:
美国
项目状态:
已结题
起止时间:
1990-05-01 至 1995-04-30

项目摘要

项目成果

JOHN C ERFURT的其他基金

相似基金

相关文献

中文摘要
翻译
这项研究的目的是测试预防客户复发的方法 员工援助计划,通过使用两项EAP服务: 与客户进行为期两年的常规治疗后随访,以及 治疗后与客户家属的例行联系,完毕 同一时期。 有酗酒、吸毒或精神/情绪问题的EAP客户将 按两个维度随机分为四组:客户随访/否 后续行动,以及家庭参与/没有家庭参与。吸食期 将需要一年的时间才能在每个 三个研究地点,分别位于芝加哥、奥斯汀和凤凰城。 后续接触者将利用预防复发的概念,如 在Marlatt和其他人的工作中开发,改编用于非 临床环境。 用于评估结果的标准衡量标准包括客户和 家庭成员关于复发、工作保留、复发次数的报告 诊断出的问题导致住院治疗 随访期的问题、随访期的伤残费用- 上行期,并为诊断出的问题和其他 在随访期内出现健康问题。
英文摘要
The aims of the study are to test methods for preventing relapse in clients of employee assistance programs, through the use of two EAP services: routine post-treatment follow-up with clients over a two-year period, and routine post-treatment contacts with a family member of the client, over the same period. EAP clients having alcohol, drug abuse, or mental/emotional problems will be randomized into four groups, along two dimensions: client follow-up/no follow-up, and family involvement/no family involvement. An intake period of one year will be required in order to sample 400 clients at each of three study sites, located in Chicago, Austin, and Phoenix. Follow-up contacts will utilize concepts of relapse prevention, as developed in the work of Marlatt and others, adapted for use in a non- clinical setting. Criterion measures to be used in evaluating results include clients' and family members' reports of relapse, job retention, number of relapses for the diagnosed problem leading to inpatient-residential treatment for that problem during the follow-up period, cost of disability during the follow- up period, and health benefits paid for the diagnosed problem and for other health problems during the follow-up period.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
EAP CLIENT FOLLOW-UP AND FAMILY INVOLVEMENT
EAP CLIENT FOLLOW-UP AND FAMILY INVOLVEMENT
LONG TERM EFFECTS OF HYPERTENSION PROGRAMS IN INDUSTRY
LONG TERM EFFECTS OF HYPERTENSION PROGRAMS IN INDUSTRY
海外基金